• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000693 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000692 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000691 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000694 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000690 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000689 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000688 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JYSB2000695 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2021-01-01 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2022-01-20 view
JXSS2000015 艾美赛珠单抗注射液 emicizumab Injection Biological Products Import Drug Application 2020-05-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2021-03-30 view
JXSS2000014 艾美赛珠单抗注射液 emicizumab Injection Biological Products Import Drug Application 2020-05-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2021-03-30 view
JXSS2000013 艾美赛珠单抗注射液 emicizumab Injection Biological Products Import Drug Application 2020-05-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2021-03-30 view
JXSS2000012 艾美赛珠单抗注射液 emicizumab Injection Biological Products Import Drug Application 2020-05-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2021-03-30 view
JYSB2000414 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-08-21 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-02 view
JYSB2000413 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-08-21 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-02 view
JYSB2000412 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-08-21 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-02 view
JYSB2000411 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-08-21 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-02 view
JYSB2000080 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-03-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-06-10 view
JYSB2000083 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-03-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-06-10 view
JYSB2000082 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-03-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-06-10 view
JYSB2000081 艾美赛珠单抗注射液 emicizumab Injection Biological Products Supplementary Application 2020-03-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-06-10 view